Russell Investments Group, Ltd. Sorrento Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.17 - $1.19 $45 - $316	266 New	266 $0
Q1 2022 May 05, 2022	SELL	$2.0 - $4.9 $6,400 - $15,680	-3,200 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$7.41 - $10.99 $23,712 - $35,168	3,200 New	3,200 $24,000
Q2 2021 Aug 04, 2021	SELL	$6.35 - $10.0 $358,660 - $564,820	-56,482 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$5.76 - $11.95 $325,336 - $674,959	56,482 New	56,482 $385,000
Q1 2019 May 13, 2019	SELL	$1.86 - $5.94 $198,683 - $634,504	-106,819 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$2.01 - $4.24 $194,503 - $410,296	-96,768 Reduced 47.53%	106,819 $256,000
Q3 2018 Oct 26, 2018	BUY	$4.22 - $7.5 $859,137 - $1.53 Million	203,587 New	203,587 $896,000
Q2 2018 Aug 08, 2018	SELL	$4.75 - $8.0 $28,096 - $47,320	-5,915 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$4.5 - $9.95 $26,617 - $58,854	5,915 New	5,915 $30,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.